Journal of Family Medicine and Primary Care · 2019 · 22 citations · 17 references
MedicinePathologyUrologyGenitourinary OncologyNeoplasiaTumor PathologyCancer BiomarkersImmunohistochemistryProstate CancerProstate PathologyTumor GradingTumor MarkersImmunohistochemical BiomarkersImmunohistochemical DetectionImmunohistochemical MarkersImmunohistochemical StainingProstate Tumor MarkersProstatic BiomarkersTumor Grade AssessmentTumor Grade Classification
AIMS AND OBJECTIVE: In recent period, basal cell markers high molecular weight cytokeratin (HMWCK), P63 and prostate biomarker AMACR have been used as adjuvant to morphology in diagnostically challenging cases with a very high sensitivity and specificity. MATERIALS AND METHODS: In this prospective study, total of 80 cases including 40 cases of malignant lesions and 40 cases of benign lesions of the prostate were taken. Tumor grade was determined according to Gleason's grading system. AMACR, HMWCK, P63 expressions were determined by immunohistochemical staining. RESULTS: = 0.001). In benign lesions, HMWCK and P63 were expressed in all the 40 (100%) cases, while in malignant lesions of prostate it was not expressed in any of the (0%) case. AMACR expression was not seen in any of the benign lesion. Out of 40 malignant cases, 4 cases were negative for AMACR, HMWCK and P63, 36 cases were positive only for AMACR, but no case was positive for HMWCK and P63. CONCLUSIONS: As an adjunct to biopsy, AMACR, HMWCK and P63 have potential for combating diagnostically challenging cases.
17
α-Methylacyl Coenzyme A Racemase as a Tissue Biomarker for Prostate Cancer
Mark A. Rubin · JAMA · 2002 · 646 citations
Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
Patrick C. Walsh · PubMed · 2002 · 477 citations
PROSPECTIVE EVALUATION OF PROSTATE CANCER DETECTED ON BIOPSIES 1, 2, 3 AND 4: WHEN SHOULD WE STOP?
Bob Djavan, V. Ravery, A. Zlotta et al. · The Journal of Urology · 2001 · 448 citations
Zhong Jiang, Bruce A. Woda, Kenneth L. Rock et al. · The American Journal of Surgical Pathology · 2001 · 368 citations
Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
Jun Luo, Shan Zha, Jessica Hicks et al. · PubMed · 2002 · 297 citations